Home Management of Children With COVID-19 in the Emilia-Romagna Region, Italy

Gianluca Vergine1, Michela Fantini2, Federico Marchetti3

  • 1Department of Pediatrics, Infermi Hospital Rimini, Azienda Sanitaria Locale Romagna, Rimini, Italy.

Frontiers in Pediatrics
|November 16, 2020
PubMed

Insights

Community health houses effectively managed children with COVID-19, with most cases being mild. This approach reduced hospitalizations and eased healthcare burdens, offering significant benefits.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) in children is typically mild or asymptomatic.
  • Despite mild disease, many children with suspected or confirmed SARS-CoV-2 are hospitalized.
  • Community-based management could alleviate hospital strain and associated issues.

Purpose of the Study:

  • To evaluate the role of community health houses (CHHs) in managing pediatric COVID-19 cases.
  • To assess the impact of CHH management on hospitalization rates and healthcare resource utilization.

Main Methods:

  • A study of 1,009 children with suspected SARS-CoV-2 infection in Italy's Emilia-Romagna Region.
  • Comparison of outcomes for children tested/managed at home by CHHs versus those tested in hospitals.
  • Analysis of demographic data, exposure history, clinical findings, and hospitalization rates.

Main Results:

  • 194 children (19.2%) tested positive for SARS-CoV-2.
  • CHHs managed the majority of children (58%), with home-managed children being older and having higher family exposure.
  • Only 0.7% of home-managed children required hospitalization, compared to 48% of hospital-tested children.

Conclusions:

  • Community health houses play a crucial role in managing pediatric COVID-19, particularly mild to moderate cases.
  • CHH-based management significantly reduces hospital admissions, benefiting families, healthcare systems, and the economy.
  • A community-centered strategy for pediatric COVID-19 management is recommended for future epidemic waves.

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
612
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.5K
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
284
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
321
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K